HB+ is proud to partner with the National Minority Health Association to help bring about health equity and close the disparity gap in health and healthcare for underserved, marginalized, hard-to-reach, and minority communities.

Glucagon-like peptide-1 (GLP-1) agonists such as Ozempic(r) or Wegovy(r) (semaglutide), Saxenda(r) (liraglutide), or Zepbound(tm) (tirzepatide), have become increasingly popular in promoting weight loss.

Read More